State Street Drops After Q4 Results: Beat on Paper, But Costs Raise Questions
State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring costs and a higher-than-expected expense outlook for 2026.
2 min read
Telegram News Wire
BSX Shares Dip as Boston Scientific Unveils Biggest Deal in 20 Years
Boston Scientific stock slipped 3.6% in premarket trading after the company announced a $14.5 billion deal to buy Penumbra.
2 min read
Why Is Ocular Therapeutix (OCUL) Stock Up Premarket Today? Sanofi Bid Rejection Fuels Rally
2 min read
Back to 
